Sector
1063 stories · page 40 of 54
Pathway is now reporting that it will expand the rollout to New Brunswick, Prince Edward Island, and Newfoundland, introducing the MCMS to Sobeys' Canadian pharmacy locations
A patient walking into a Ketamine One clinic in North America can expect to be offered a range of treatments, including psychedelic-assisted options, from a skilled medical professional and guided by cutting-edge technology as part of the t
Lakmaaker has more than 20 years of executive experience, including in financial and corporate communications, corporate finance and marketing
Ketamine One will leverage its experience in ketamine-assisted therapies and innovative treatments, including integrating immersive virtual reality, towards creating a first-of-its-kind healing experience specifically for veterans suffering
NASDAQ-listed Enveric Biosciences Inc. announced on May 24, 2021, that it has entered into a definitive agreement for an all-stock transaction to acquire the biotechnology company
The company's Software-as-a-Service (SaaS) revenue comprises about 75% of its total revenue for the year, which is projected to exceed C$1.5 million
PCSG, practising since 2006 and with a team of 35 health professionals, provides individual psychotherapy, couple/family therapy, psychological, as well as psycho-educational assessment and intervention for children, youth and adults
The company said the arrangement with Illumma LLC “bolsters the company’s proposed network of six clinics” in the US
Steven McAuley, chairman and CEO of Empower Clinics said: "This is getting exciting, we are onto something special, The Medi-Collective, it's a launch!"
Pathway said the acquisition adds approximately 4,000 new, active patients to the company's existing base of over 55,000 medical cannabis patients and expands its telemedicine footprint in several provinces including British Columbia and th
“We have developed so much experience over the years through the cannabis industry and we genuinely believe we can now bring that to bear on the development of the psychedelics field in Australia,” says MD.
Cognetivity’s tool is a cognitive testing platform that offers a five-minute, computerized assessment that is suited to long-term mental health monitoring
The company, which is focused on treatments for depression and related conditions, said revenue for the three months came in at C$407,075
The four clinics will be located in the Comox Valley, Ottawa, Halifax, and Surrey
The study will demonstrate that it can effectively conduct a randomized controlled trial using psychedelic-assisted therapy, enabling it to build the infrastructure for future studies and future clinical care
“The investment in Brainworks demonstrates MMJ’s expertise to secure a private negotiated investment in unlisted businesses which are not generally available to Australian retail and institutional investors,” says chairman.
MGC Pharmaceuticals Ltd has been a huge winner today, up 43.59%. MXC has signed a landmark deal with an American drug distributor worth a minimum US$24 million over the next three years.
The company said it ended the period to June 30 this year with $6.4 million (m) in cash
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
The company expects to add other members to the foundational board in due course, as appropriate